Thermo Fisher (TMO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Daniel

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $614.16 which represents a decrease of $-4.30 or -0.70% from the prior close of $618.46. The stock opened at $615.71 and touched a low of $604.

Shares of Thermo Fisher Scientific Inc. TMO advanced 1.66% to $620.25 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,

Bank of America Securities analyst Michael Ryskin has reiterated their bullish stance on TMO stock, giving a Buy rating today. Michael Ryskin